查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲直接面向消费者的基因测试市场预测至 2030 年 - 区域分析 - 按测试类型、技术和配销通路
市场调查报告书
商品编码
1463720

欧洲直接面向消费者的基因测试市场预测至 2030 年 - 区域分析 - 按测试类型、技术和配销通路

Europe Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 77 Pages | 订单完成后即时交付

价格

2022年欧洲直接面向消费者的基因检测市场价值为5.0798亿美元，预计到2030年将达到21.0366亿美元；预计2022年至2030年CAGR为19.4%。

人们对基因检测潜在益处的认识不断增强，推动了欧洲直接面向消费者的基因检测市场

消费者越来越受到自我好奇心和赋权的驱动，这反映在对提供基因检测和后续咨询的服务意识的增强。全世界人民对基因检测的认识和接受度正在稳步提高。客户从被动向自主和自我意识的转变正在推动基因检测市场的发展。直接面向消费者的基因检测 (DTC-GT) 固有的可访问性是一个主要优势，它使消费者可以免费获得其基因资讯以及个人化的见解和建议。许多行业都发现寻求客製化产品和体验的客户显着增加，并且为识别和满足个人需求而付费的意愿也增强。

Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the状态.基因检测在医学各领域的角色正在迅速增强。基因检测已经在加快诊断速度，并有助于识别具有高復原力疾病遗传倾向的人。孕前和产前基因检测可告知潜在患者其遗传性疾病带因者状况，从而帮助他们做出生殖决定。

人们越来越认识到与不同疾病相关的各种表型的遗传变异的重要性，预计将进一步促进市场成长。这些测试揭示了一个人是否具有某种特定疾病或相关表型的遗传倾向，可以儘早诊断并开始疾病治疗。人类基因组的首次定序和基因组定序技术的进步促进了基因组学研究的快速发展。这也导致直接面向消费者的基因检测成为一项新服务。欧洲直接面向消费者的基因检测市场影响了许多人，因为这些检测提供了有关各种健康风险、个人特征和整体福祉的有效资讯。此外，临床实验室人员快速过渡到 DTC-GT 是推动市场的另一个关键因素。例如，根据《麻省理工科技评论》的报导，2019 年，约 8%（即近 2,600 万人）的美国人接受了 DNA 检测。

因此，人们对基因检测的认识不断增强，推动了直接面向消费者的基因检测市场的发展。

欧洲直接面向消费者的基因检测市场概述

欧洲直接面向消费者的基因检测市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。由于人们对基因检测的认识不断提高，以及遗传性疾病和癌症盛行率的上升，预计该区域市场在未来几年将显着增长。过去几年技术的不断进步为直接面向消费者的基因检测市场的扩张带来了无数机会。针对利基治疗领域的客製化检测试剂盒的开发和慢性病盛行率的上升有利于德国直接面向消费者的基因检测市场。此外，随着个体基因组定序成本呈指数下降，遗传学在临床实践中变得至关重要。遗传学为医生提供了宝贵的症状前诊断，在某些情况下还提供了分析工具，可用于更有效地管理疾病并采取预防措施。基因组分析工具价格的指数下降也使个人能够快速、经济地获得他们的基因图谱。

据德国癌症研究中心称，2022年德国有近69,000名女性和700-800名男性被诊断出乳癌。德国政府宣布计划将乳癌基因1（BRCA）基因检测纳入国家癌症计划，该计划于2008年启动，旨在确保具有较高乳癌遗传风险的女性依法有权获得全面的乳癌基因检测。查和降低风险的选择。德国政府越来越注重监管和提高人们对基因测试的认识，促使德国各地采用直接面向消费者的基因测试。

欧洲直接面向消费者的基因检测市场收入和 2030 年预测（百万美元）

欧洲直接面向消费者的基因检测市场区隔

欧洲直接面向消费者的基因测试市场分为测试类型、技术、配销通路和国家。

根据测试类型，欧洲直接面向消费者的基因测试市场分为血统测试、预测测试、营养基因组学测试、带因者测试等。 2022 年，血统测验细分市场占据最大份额。

从技术上来看，欧洲直接面向消费者的基因检测市场分为全基因组定序、单核苷酸多态性晶片、标靶分析等。 2022年，单核苷酸多态性晶片领域占据最大份额。

根据配销通路，欧洲直接面向消费者的基因检测市场分为线上和线下。 2022 年，线上细分市场占据了更大的份额。

根据国家/地区，欧洲直接面向消费者的基因检测市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲直接面向消费者的基因检测市场占据主导地位。

Ancestry Genomics Inc、Myriad Genetics, Inc.、Living DNA Ltd、23andMe Inc 和 Genetic Technologies Ltd 是欧洲直接面向消费者基因检测市场的一些领先公司。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲直接面向消费者的基因检测市场格局

  • 概述

第 5 章：欧洲直接面向消费者的基因检测市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病的发生率不断上升
    • 提高对基因检测潜在益处的认识
  • 市场限制
    • 与直接面向消费者的基因检测相关的高成本和隐私问题
  • 市场机会
    • 单核苷酸多态性 (SNP) 晶片的采用日益广泛
  • 未来的趋势
    • 人们对药物基因学的兴趣日益浓厚，远距医疗的采用也不断增加
  • 影响分析

第 6 章：直接面向消费者的基因检测市场 - 欧洲市场分析

  • 欧洲直接面向消费者的基因检测市场收入，2022 - 2030

第 7 章：欧洲直接面向消费者的基因测试市场 - 收入和 2030 年预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年欧洲直接面向消费者的基因测试市场收入份额，按测试类型划分 (%)
  • 血统测试
  • 营养基因组学测试
  • 预测测试
  • 运营商测试
  • 其他的

第 8 章：欧洲直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年欧洲直接面向消费者的基因检测市场收入份额（按技术划分）（%）
  • 全基因组定序
  • 单核苷酸多态性晶片
  • 针对性分析
  • 其他的

第 9 章：欧洲直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按配销通路

  • 概述
  • 2022 年和 2030 年欧洲直接面向消费者的基因检测市场收入份额（按配销通路划分）（%）
  • 线上平台
  • 线下平台

第 10 章：欧洲直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 国家分析

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 余下的

第 11 章：欧洲直接面向消费者的基因检测市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：公司简介

  • Ancestry Genomics Inc
  • Genetic Technologies Ltd
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 23andMe Inc

第 13 章：附录

Product Code: BMIRE00029623

The Europe direct-to-consumer genetic testing market was valued at US$ 507.98 million in 2022 and is expected to reach US$ 2,103.66 million by 2030; it is estimated to grow at a CAGR of 19.4% from 2022 to 2030.

Increasing Awareness About Potential Benefits of Genetic Testing Fuels the Europe Direct-to-Consumer Genetic Testing Market

Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing is steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs.

Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders.

The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and advances in genome sequencing technology have enabled rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. The Europe direct-to-consumer genetic testing market has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. For example, according to MIT Technology Review, approximately 8%, or nearly 26 million, people in the US took DNA tests in 2019. That number is expected to rise to over 100 million in the coming years.

Thus, the growing awareness among the population regarding genetic testing drives the direct-to-consumer genetic testing market.

Europe Direct-to-Consumer Genetic Testing Market Overview

The Europe direct-to-consumer genetic testing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising awareness regarding genetic tests, and rising prevalence of genetic disorders and cancer. The rising technological advancements in the past few years have opened numerous opportunities for the direct-to-consumer genetic testing market expansion. The development of customized testing kits for niche therapeutic areas and rising prevalence of chronic diseases benefits the direct-to-consumer genetic testing market in Germany. Moreover, genetics has become vital in clinical practices with an exponential drop in the cost of an individual's genome sequencing. Genetics provides doctors with valuable presymptomatic diagnostic and, in some cases, analytical tools, which can be used to manage diseases more effectively and take preventive actions. The exponential fall in the price of genome analysis tools also allows individuals to access their genetic profiles quickly and economically.

According to the German Cancer Research Center, breast cancer was diagnosed in nearly 69,000 women and 700-800 men in Germany in 2022. This makes breast cancer one of the most frequently occurring cancers in Germany. The government of Germany announced a plan to include Breast Cancer gene 1 (BRCA) genetic testing in the national cancer plan, which was initiated in 2008 with an aim to ensure women who are at a higher genetic risk of breast cancer are legally entitled to thorough screening and risk-reducing options. The increasing focus of the German government on regulating and creating awareness regarding genetic tests triggers the adoption of direct-to-consumer genetic tests across Germany.

Europe Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

Europe Direct-To-Consumer Genetic Testing Market Segmentation

The Europe direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the Europe direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the Europe direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the Europe direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the Europe direct-to-consumer genetic testing market is segmented Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe direct-to-consumer genetic testing market in 2022.

Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the Europe direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. Europe Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - Europe Market Analysis

  • 6.1 Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 Germany: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 Germany: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Germany: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 Germany: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Germany: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 UK: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 UK: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 UK: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 UK: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 UK: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 France: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 France: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 France: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 France: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 France: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.7 Italy: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.8 Italy: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.8.1 Italy: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.8.2 Italy: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.8.3 Italy: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.9 Spain: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.10 Spain: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.10.1 Spain: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.10.2 Spain: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.10.3 Spain: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.11 Rest of Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.12 Rest of Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.12.1 Rest of Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.12.2 Rest of Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.12.3 Rest of Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Europe Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Ancestry Genomics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Genetic Technologies Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Myriad Genetics, Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Living DNA Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 23andMe Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. Germany Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Italy Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Italy Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Italy Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Spain Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Spain Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Spain Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Europe Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. Europe Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. Europe Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. Europe Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. Europe Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 21. Germany: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. UK: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. France: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Italy: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Spain: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Rest of Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)